SCHEMBL29930773

SCHEMBL29930773

COc1ccc(-c2n[nH]c3ncc(-c4ccc(NC(N)=O)cc4)cc23)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 5/20 0.70
DYRK1A Q13627 4/20 0.57
CLK1 P49759 2/20 0.51
DYRK2 Q92630 2/20 0.51
TTK P33981 1/20 0.47
MAPK8 P45983 1/20 0.47
KIT P10721 1/20 0.47
CDK2 P24941 2/20 0.45
CCNE2 O96020 1/20 0.45
CDK4 P11802 1/20 0.45
CCND1 P24385 1/20 0.45
CCNE1 P24864 1/20 0.45
AAK1 Q2M2I8 2/20 0.45
LRRK2 Q5S007 1/20 0.44
ACR P10323 1/20 0.44
LIMK1 P53667 1/20 0.43
ROCK1 Q13464 1/20 0.43
CHEK2 O96017 1/20 0.43
KDR P35968 1/20 0.43
TEK Q02763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930667 0.90 DYRK1B (0.70) DYRK1BDYRK1ACLK1DYRK2TTK
SCHEMBL29930308 0.86 DYRK1B (0.68) DYRK1BDYRK1ACLK1DYRK2CDK2
SCHEMBL29930898 0.79 DYRK1A (0.65) DYRK1BDYRK1AKITAAK1
SCHEMBL12845568 0.78 KIF11 (0.65) DYRK1BKDRTEK
SCHEMBL29930317 0.77 DYRK1B (0.68) DYRK1BDYRK1ACLK1DYRK2TTK
SCHEMBL29930500 0.76 DYRK1A (0.47) DYRK1BDYRK1AKITCDK2CCNE2
SCHEMBL5536712 0.74 KIT (0.46) DYRK1BDYRK1AKITCDK2AAK1
SCHEMBL30912734 0.73 HDAC1 (0.50) DYRK1BDYRK1AAAK1
SCHEMBL29253948 0.73 HDAC1 (0.50) DYRK1BDYRK1AAAK1
SCHEMBL28562998 0.73 DYRK1B (0.61) DYRK1BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO claimed
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed